Erkki Soini

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Venues

Advances in therapy

ClinicoEconomics and outcomes research : CEOR

Kauneuskeskus Mona Oy

Kuopio University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kauneuskeskus Mona Oy

Finland

Vice Member of the Board

Kauneuskeskus Mona Oy

Finland

Consultant

ESiOR Oy

Finland

Vice President of the Board

ESiOR Oy

Finland

CEO and Consultant

ESiOR Oy

Finland

Member of the Board

ESiOR Oy

Finland

Entrepreneur/Senior Partner

University of Eastern Finland

Finland

Part-time university lecturer

International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Czechia

Scientific Review Committee Chair

ESiOR Oy

Finland

CFO

Kuopio University

Finland

Researcher

ESiOR Oy

Finland

Founder

Farm

Finland

Part-time agricultural stand-ins

Finnish Office for Health Technology Assessment (FinOHTA)

Finland

Trainee

Southern Osthrobothnia Hospital District

Finland

RNS (anaesthesiology)

Finnish defence forces

Finland

Compulsory military service (2nd liutenant)

S-Market

Finland

Part-time salesman

Education History

Kuopio University

Finland

MSC

Kuopio University

Finland

BSC

Kuopio University

Finland

BSC

Publications

Taru Hallinen, Santtu Kivelä, Erkki Soini, Veli-Pekka Harjola, Mari Pesonen
Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Taru Hallinen, Santtu Kivelä, Erkki Soini, Veli-Pekka Harjola, Mari Pesonen
Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Antti Puolitaival, Mikko Savola, Petri Tuomainen, Christian Asseburg, Tuomas Lundström, Erkki Soini
Advantages in Management and Remote Monitoring of Intravenous Therapy: Exploratory Survey and Economic Evaluation of Gravity-Based Infusions in Finland. Advances in therapy 39 (5) (2022)
Taru Hallinen, Erkki Soini, Christian Asseburg, Miika Linna, Pia Eloranta, Sari Sintonen, Mikko Kosunen
Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atrial Fibrillation. ClinicoEconomics and outcomes research : CEOR 13 (2021)
Erkki Soini, Outi Virtanen, Saku Väätäinen, Jean-Baptiste Brière, Kevin Bowrin, Aurelie Millier
Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland. Advances in therapy 37 (7) (2020)
Saku Väätäinen, Erkki Soini, Jukka Peltola, Mata Charokopou, Maarit Taiha, Reetta Kälviäinen
Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland. Advances in therapy 37 (1) (2019)
Petri Mankinen, Tuomas Lundström, Erkki Soini, Marja-Liisa Sumelahti, Juhani Ruutiainen, Ulla Niskala, Elina Järvinen
Cost Assessment Modelling of Treatments for Highly Active Relapsing Multiple Sclerosis. Advances in therapy 37 (2) (2019)

Erkki Soini.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Erkki Soini